Endocrine regulation of suppressor lymphocytes: Role of the glucocorticoid-induced TNF-like receptor

Annals of the New York Academy of Sciences

Volumn 1069, Issue , 2006, Pages 377-385

  Negrini, Simone ^a   Fenoglio, Daniela ^a   Balestra, Piercesare ^a   Fravega, Marco ^a   Filaci, Gilberto ^a   Indiveri, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

GITR; GITRL; Glucocorticoid hormones; T regulatory lymphocytes; T suppressor lymphocytes

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNITY; CANCER; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; CYTOTOXICITY; GENE; GENE EXPRESSION; GITR GENE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE; RECEPTOR INTRINSIC ACTIVITY; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION;

EID: 33745592736     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1351.035     Document Type: Conference Paper

References (62)

1. STEINMAN, L. 2004. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5: 575-581.
2. BESEDOVSKY, H. et al. 1996. Immune-neuro-endocrine interactions: facts and hypothesis. Endocr. Rev. 18: 206-228.
3. TURNBULL, A.V. et al. 1999. Regulation of the hypothalamic-pituitary- adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 79: 1-71.
4. WILDER, R.L. 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13: 307-338.
5. CHROUSOS, G. 1998. Stressors, stress and neuroendocrine integration of the adaptive response. Ann. N.Y. Acad Sci. 851: 311-335.
6. STRAUB, R.H., M. CUTOLO, B. ZIETZ, et al. 2001. The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech. Ageing Dev. 122: 1591-1611.
7. COLE, T.J. et al. 2005. Intrathymic glucocorticoid production and thymocyte survival: another piece in the puzzle. Endocrinology 146: 2499-2500.
8. TUCKERMANN, J.P. et al. 2005. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Clin. Lab. Sci. 42: 71-104.
9. REICHARDT, H.M. 2004. Immunomodulatory activities of glucocorticoids: insights from transgenesis and gene targeting. Curr. Pharm. Des. 10: 2797-2805.
10. ELENKOV, I.J. 2004. Glucocorticoids and the Th1/Th2 balance. Ann. N.Y. Acad. Sci. 1024: 138.
11. CUTOLO, M. et al. 2003. Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Ann. N.Y. Acad. Sci. 992: 107-117.
12. KUMAR, R. et al. 2005. Gene regulation by the glucocorticoid receptor: structure: function relationship. J. Steroid. Biochem. Mol. Biol. 94: 383-394.
13. SMOAK, K.A. et al. 2004. Mechanisms of glucocorticoid receptor signaling during inflammation. Mech. Ageing Dev. 125: 697-706.
14. SCUDELETTI, M. et al. 1999. Immune regulatory properties of corticosteroids: prednisone induces apoptosis of human T lymphocytes following the CD3 down-regulation. Ann. N.Y. Acad. Sci. 876: 164-179.
15. SCUDELETTI, M. et al. 1990. New glucocorticoids: mechanisms of immunological activity at the cellular level and in the clinical setting. Ann. N. Y. Acad. Sci. 595: 368-382.
16. INDIVERI, F. et al. 1983. Inhibitory effect of a low dose of prednisone on PHA-induced Ia antigen expression by human T cells and on proliferation of T cells stimulated with autologous PHA-T cells. Cell Immunol. 80: 320-328.
17. SCUDELETTI, M. et al. 1999. Immune regulatory properties of corticosteroids: prednisone induces apoptosis of human T lymphocytes following the CD3 down-regulation. Ann. N.Y. Acad. Sci. 876: 164-179.
18. FRANCHIMONT, D. 2004. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann. N.Y. Acad. Sci. 1024: 124-137.
19. LANZA, L. et al. 1996. Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin. Exp. Immunol. 103: 482-490.
20. +) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
21. KARAGIANNIDIS, C. et al. 2004. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114: 1425-1433.
22. MATYSZAK, M.K. et al. 2000. Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30: 1233-1242.
23. NOCENTINI, G. et al. 1997. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94: 6216-6221.
24. WAJANT, H. et al. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65.
25. MACEWAN, D. 2002. TNF ligands and receptors - a matter of life and death. Br. J. Pharmacol. 135: 855-875.
26. GURNEY, A.E. et al. 1999. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr. Biol. 9: 215-218.
27. SHIMIZU, J. et al. 2002. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3: 135-142.
28. JI, H.B. et al. 2004. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J. Immunol. 172: 5823-5827.
29. RONCHETTI, S. et al. 2002. Role of GITR in activation response of T lymphocytes. Blood 100: 350-352.
30. MCHUGH, R.S. et al. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
31. LI, Z. et al. 2003. Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J. Autoimmun. 21: 83-92.
32. ZELENIKA, D. et al. 2002. Regulatory T cells overexpress a subset of Th2 gene transcripts. J. Immunol. 168: 1069-1079.
33. + T suppressor cell clones produce transforming growth factor, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196: 1335-1346.
34. SHIN, H.H. et al. 2002. Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induces NOS in murine macrophages. FEBS Lett. 514: 275-280.
35. KIM, J.D. et al. 2003. Cloning and characterization of GITR ligand. Genes Immun. 4: 564-569.
36. KWON, B. et al. 1999. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J. Biol. Chem. 274: 6056-6061.
37. TONE, M. et al. 2003. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is co-stimulatory for T cells. Proc. Natl. Acad. Sci. USA 100: 15059-15064.
38. + T cells. J. Immunol. 172: 7306-7314.
39. SPINICELLI, S. et al. 2002. GITR interacts with the pro-apoptotic protein Siva and induces apoptosis. Cell Death Differ. 9: 1382-1384.
40. PRASAD, K.V. et al. 1997. CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc. Natl. Acad. Sci. USA 94: 6346-6351.
41. MURIGLAN, S.J. et al. 2004. GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease. J. Exp. Med. 200: 149-157.
42. + T cells from tolerized (New Zealand Black x New Zealand White) F1 mice suppress in vitro production of antibodies to DNA. J. Immunol. 173: 3542-3548.
43. NOCENTINI, G. et al. 2005. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur. J. Immunol. 35: 1016-1022.
44. SURI, A. et al. 2004. Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor. Eur. J. Immunol. 34: 447-454.
45. + T cell activation and experimental autoimmune encephalomyelitis. J. Immunol. 172: 4686-4690.
46. CUZZOCREA, S. et al. 2004. Glucocorticoid-induced TNF receptor family gene (GITR) knockout mice exhibit a resistance to splanchnic artery occlusion (SAO) shock. J. Leukoc. Biol. 76: 933-940.
47. DITTMER, U. et al. 2004. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 20: 293-303.
48. CALMELS, B. et al. 2005. Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L. Cancer Gene Ther. 12: 198-205.
49. GERSHON, R.K. et al. 1971. Infectious immunological tolerance. Immunology 21: 903-913.
50. DIECKMANN, D. et al. 2001. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 193: 1303-1310.
51. JONULEIT, H. et al. 2002. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193: 1285-1294.
52. BANCHEREAU, J. et al. 2001. Dendritic cells and the control of immunity. Nature 392: 245-252.
53. CASSIS, L. S. AIELLO & M. NORIS. 2005. Natural versus adaptive regulatory T cells. Contrib. Nephrol. 146: 121-131.
54. DAMLE, N.K. et al. 1989. Antigen-specific suppressor T lymphocytes in man. Clin. Immunol. Immunopathol. 53: S17-S24.
55. SERCARZ, E. et al. 1991. The distinctive specificity of antigen-specific suppressor T cells. Immunol. Today 12: 111-118.
56. + cells in myasthenia gravis patients and in healthy controls. J. Immunol. 154: 1508-1520.
57. + T suppressor cells are back to the game: are they players in autoimmunity? Autoimmun. Rev. 1: 279-283.
58. + T suppressor lymphocytes. Clin. Exp. Med. 4: 86-92.
59. -. T cells and inhibit both T-cell proliferation and CTL function. Hum. Immunol. 65: 142-156.
60. + T cells is mediated by interferon-γ and is defective in chronic progressive multiple sclerosis. J. Clin. Invest. 95: 2711-2719.
61. + T suppressor cell function in patients with active systemic lupus erythematosus. J. Immunol. 166: 6452-6457.
62. + T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann. N.Y. Acad. Sci. 1050: 115-123.